Literature DB >> 11493609

Insights into molecular mechanisms of contact hypersensitivity gained from gene knockout studies.

B Wang1, C Feliciani, I Freed, Q Cai, D N Sauder.   

Abstract

Contact hypersensitivity (CHS), a dendritic-cell (DC)-dependent, T-cell-mediated skin immune response to reactive haptens, has been a subject of intense research for many years. The molecular mechanisms underlying CHS are complicated and are not fully understood. During the past few years, varieties of gene-targeted knockout mice have been used in the study of CHS. Such studies have contributed significantly to our understanding of the mechanisms responsible for the initiation of CHS. This review focuses on insights into molecular requirements for CHS gained from knockout studies.

Entities:  

Mesh:

Year:  2001        PMID: 11493609

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

1.  JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis.

Authors:  Katja Denninger; Susanne Rasmussen; Jeppe Madura Larsen; Catrine Orskov; Steen Seier Poulsen; Poul Sørensen; Jan Pravsgaard Christensen; Harald Illges; Niels Odum; Tord Labuda
Journal:  Am J Pathol       Date:  2011-08-11       Impact factor: 4.307

2.  Preventive and therapeutic potential of placental extract in contact hypersensitivity.

Authors:  Youn Son Kim; Jang-June Park; Yukimi Sakoda; Yuming Zhao; Katsuya Hisamichi; Tai-Ichi Kaku; Koji Tamada
Journal:  Int Immunopharmacol       Date:  2010-07-07       Impact factor: 4.932

3.  The differential role of L-selectin and ICAM-1 in Th1-type and Th2-type contact hypersensitivity.

Authors:  Asako Ogawa; Ayumi Yoshizaki; Koichi Yanaba; Fumihide Ogawa; Toshihide Hara; Eiji Muroi; Motoi Takenaka; Kazuhiro Shimizu; Minoru Hasegawa; Manabu Fujimoto; Thomas F Tedder; Shinichi Sato
Journal:  J Invest Dermatol       Date:  2010-02-25       Impact factor: 8.551

4.  Leucocyte-associated immunoglobulin-like receptor-1 is an inhibitory regulator of contact hypersensitivity.

Authors:  Ryusuke Omiya; Fumihiko Tsushima; Hidehiko Narazaki; Yukimi Sakoda; Atsuo Kuramasu; Youn Kim; Haiying Xu; Hideto Tamura; Gefeng Zhu; Lieping Chen; Koji Tamada
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

5.  Differential effects of peptidoglycan recognition proteins on experimental atopic and contact dermatitis mediated by Treg and Th17 cells.

Authors:  Shin Yong Park; Dipika Gupta; Chang H Kim; Roman Dziarski
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

6.  Estriol strongly inhibits DNCB-induced contact dermatitis: role of antigen-specific antibodies in pathogenesis.

Authors:  Elizabeth Yan Zhang; Bao-Ting Zhu
Journal:  Endocr Connect       Date:  2014-08-22       Impact factor: 3.335

7.  Sensory TRP channels contribute differentially to skin inflammation and persistent itch.

Authors:  Jing Feng; Pu Yang; Madison R Mack; Dariia Dryn; Jialie Luo; Xuan Gong; Shenbin Liu; Landon K Oetjen; Alexander V Zholos; Zhinan Mei; Shijin Yin; Brian S Kim; Hongzhen Hu
Journal:  Nat Commun       Date:  2017-10-30       Impact factor: 14.919

8.  Mechanism of dinitrochlorobenzene-induced dermatitis in mice: role of specific antibodies in pathogenesis.

Authors:  Elizabeth Yan Zhang; Aaron Yun Chen; Bao Ting Zhu
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

9.  Extract of Rhus verniciflua Bark Suppresses 2,4-Dinitrofluorobenzene-Induced Allergic Contact Dermatitis.

Authors:  Dong Ki Park; Yang Gi Lee; Hye-Jin Park
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-24       Impact factor: 2.629

10.  Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1.

Authors:  Miyako Nagamachi; Daiji Sakata; Kenji Kabashima; Tomoyuki Furuyashiki; Takahiko Murata; Eri Segi-Nishida; Kitipong Soontrapa; Toshiyuki Matsuoka; Yoshiki Miyachi; Shuh Narumiya
Journal:  J Exp Med       Date:  2007-10-29       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.